Nav: Home

Staying healthy during WorldPride 2017

May 16, 2017

ECDC has published a rapid risk assessment to assess the risk of outbreaks and transmission of communicable diseases during the WorldPride festival period taking place in Madrid in June 2017.

For respiratory and vector-borne diseases, the risk is considered low, for food and waterborne diseases the risk is low to moderate, for vaccine-preventable diseases, it is moderate and for sexually transmitted infections, the risk is moderate to high.

WorldPride Madrid 2017 is the global lesbian, gay, bisexual and transgender festival to held in Madrid between 23 June and 2 July 2017. Due to the current epidemiological situation in Spain and rest of the EU, prior to attendance, participants should consider seeking advice from their healthcare provider and ensure they have valid health insurance or obtain a European Health Card, if applicable.

They should ensure they are up to date with routine vaccination courses and boosters as recommended in their EU country of residence, and discuss the need for additional vaccinations or booster doses.

In addition, participants should obtain advice on STI-prevention prior to attendance. Men who have sex with men (MSM) in particular, should check their vaccination status against hepatitis A and B, in the context of the ongoing hepatitis A virus (HAV) infection outbreaks affecting MSM in EU countries. They should also ask their healthcare provider about national recommendations on HIV pre-exposure prophylaxis (PrEP).

During the event, participants should follow standard hygiene measures and advice on the prevention of food and waterborne diseases to decrease the risk of gastrointestinal illness, and consider general hygiene practices when consuming food and drink. Participants should practice safer sex using condoms to prevent sexually transmitted infections, including HIV and hepatitis B and C.

They should also avoid faecal-oral exposure during sexual activity and ensure proper personal hygiene to prevent other infections.

After the event, if experiencing symptoms of infection or in case of unprotected sexual contact with a person or persons of unknown infection status, the participants should contact a healthcare provider for advice on testing for STI, including HIV and viral hepatitis. They could also use the European Test Finder to identify the most conveniently located testing centre.

Outbreaks and spread of vaccine-preventable diseases are of particular concern during mass gatherings of any type due to the large number of people gathering in a concentrated geographical area.
Read the ECDC rapid risk assessment:

Potential public health risks related to communicable diseases at the WorldPride festival in Madrid, 23 June-2 July 2017

Read the rapid risk assessment on the current hepatitis A outbreaks among men who have sex with men in Europe

European Centre for Disease Prevention and Control (ECDC)

Related Hepatitis Articles:

Hepatitis B: New therapeutic approach may help to cure chronic hepatitis B infection
Researchers at Helmholtz Zentrum München, Technical University of Munich (TUM) and the German Center for Infection Research (DZIF) have developed a novel therapeutic approach to cure chronic hepatitis B.
Anti-hepatitis medicine surprises
A new effective treatment of hepatitis C not only combats the virus, but is also effective against potentially fatal complications such as reduced liver functioning and cirrhosis.
Nanotechnology delivers hepatitis B vaccine
X-ray imaging shows that nanostructured silica acts as a protective vehicle to deliver intact antigen to the intestine so that it can trigger an immune response.
Checkmate for hepatitis B viruses in the liver
Researchers at Helmholtz Zentrum München and the Technical University of Munich, working in collaboration with researchers at the University Medical Center Hamburg-Eppendorf and the University Hospital Heidelberg, have for the first time succeeded in conquering a chronic infection with the hepatitis B virus in a mouse model.
How common is Hepatitis C infection in each US state?
Hepatitis C virus infection is a major cause of illness and death in the United States and injection drug use is likely fueling many new cases.
New strains of hepatitis C found in Africa
The largest population study of hepatitis C in Africa has found three new strains of the virus circulating in the general population in sub-Saharan Africa.
High stability of the hepatitis B virus
At room temperature, hepatitis B viruses (HBV) remain contagious for several weeks and they are even able to withstand temperatures of four degrees centigrade over the span of nine months.
Findings could lead to treatment of hepatitis B
Researchers have gained new insights into the virus that causes hepatitis B -- a life-threatening and incurable infection that afflicts more than 250 million people worldwide.
How to cure more hepatitis C patients
The cost of cures for hepatitis C have been prohibitive, but experts who served on an NAS panel have a solution that will save more patients and incentivize drug innovation.
Hepatitis C: A novel point-of-care assay
One of the major challenges identified by the WHO in efforts to eradicate the hepatitis C virus is the diagnosis of chronic cases that are generally asymptomatic.
More Hepatitis News and Hepatitis Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at